KLRK1 and neoplasm: However, due to the facts that mice do not express human MIC and the human onco-immune dynamics of NKG2D ligand shedding and tumor progression have not been described in these mouse models, the impact of tumor-derived immune suppressive sMIC on the therapeutic potential of ALT-803 remains unknown.